Companies: 10,795·Total market cap: $144.5T
Johnson & Johnson

Johnson & Johnson

JNJNYSEHealthcare● Active
$232.77
+$4.60(+2.02%)
Market Cap$560.3B
P/E Ratio—
52W High$251.71
52W Low$149.04
Overview

Johnson & Johnson (JNJ) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

JNJ · cash on hand · updated Dec 28, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$20.10B▼ -18.0% vs prior year
FY · as of Dec 28, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$19.71B
cashAndCashEquivalents
Short-Term Investments
$393.0M
shortTermInvestments
YoY Change vs Prior Year
-18.0%
vs prior fiscal year
Latest Quarter
$22.05B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 28, 2025

Net cash vs debt

Cash & ST Investments$20.10BCash on Hand
Total Debt$47.93BTotal Debt
Net Cash / Net Debt−$27.83BNet Debt Position
Cash vs Debt Ratio
Cash 30%Debt 70%

Johnson & Johnson carries a net debt position of $27.83B. Total debt ($47.93B) exceeds cash on hand ($20.10B). Johnson & Johnson cash vs debt ratio: 30% cash / 70% debt.

Net Cash = Cash & ST Investments − Total Debt$20.10B − $47.93B = −$27.83B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
JNJ annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 28, 2025Latest$20.10B-18.0%
Dec 29, 2024$24.52B+7.0%
Dec 31, 2023$22.93B+2.9%
Jan 1, 2023$22.28B-29.5%
Jan 2, 2022$31.61B+25.5%
JNJ cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%
#2
Johnson & Johnson
Johnson & JohnsonYOU
JNJ
$20.10B3.6%
#3
Merck & Co., Inc.
Merck & Co., Inc.
MRK
$14.56B4.9%#4
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Johnson & Johnson (JNJ) cash on hand as of December 28, 2025 is $20.10B, comprising $19.71B in cash and cash equivalents (CCE) plus $393.0M in short-term investments — reported as Johnson & Johnson cash and short-term investments on the balance sheet (10-K filing). Also referred to as Johnson & Johnson cash reserves or cash position.

Johnson & Johnson annual cash on hand history shows decreased -18.0% in 2025: decreased -18.0% in 2025. Johnson & Johnson cash reserves in 2025 reflect the company's capital allocation strategy.

Johnson & Johnson carries total debt of $47.93B against cash of $20.10B, resulting in a net debt position of -$27.83B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

JNJ cash on hand · 5 questions

As of December 28, 2025, Johnson & Johnson (JNJ) has $20.10B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $19.71B in cash and cash equivalents (CCE) plus $393,000,000 in short-term investments. Latest quarter (March 29, 2026): $22.05B. Data sourced from the annual 10-K filing via FMP.

JNJ cash on handJNJ cash reservesJNJ cash 2025how much cash does JNJ have

▸ Source: FMP /balance-sheet-statement · US GAAP · Johnson & Johnson · Johnson & Johnson SEC 10-K & 10-Q filings · US GAAP · Last updated: December 28, 2025